Molecular characterization of the vascular features of focal nodular hyperplasia and hepatocellular adenoma: A role for angiopoietin-1

Hepatology

Volumn 52, Issue 2, 2010, Pages 540-549

  Gouw, Annette S H ^a   Zeng, Wenjiao ^a,b   Buiskool, Marijke ^a   Platteel, Inge ^a   Van Den Heuvel, Marius C ^a,c   Poppema, Sibrand ^a   De Jong, Koert P ^a   Molema, Grietje ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b FUDAN UNIVERSITY   (China)

^c Department of Pathology   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CD34 ANTIGEN; PROTEIN TYROSINE KINASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; LIVER ADENOMA; LIVER CIRCULATION; NODULAR HYPERPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMA, LIVER CELL; ADULT; ANGIOPOIETIN-1; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; LIVER NEOPLASMS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 77955691332     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23700     Document Type: Article

References (26)

1. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. HEPATOLOGY 1997;26:891-895.
2. Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. HEPATOLOGY 1985;5:1194-1200.
3. Wanless I, Sapp H, Guindi M, Olshansky D, Takayama A. The pathogenesis of focal nodular hyperplasia: an hypothesis based on histologic review of 20 lesions including 3 occurring in early biliary cirrhosis [Abstract]. HEPATOLOGY 2006;44(Suppl 1):491A.
4. Bioulac-Sage P, Balabaud C, Bedossa P, Scoazec JY, Chiche L, Dhillon AP, et al. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007;46:521-527.
5. Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J, Cunha A, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. HEPATOLOGY 2007;46:740-748.
6. Paradis V, Bieche Y, Dargere D, Laurendeau I, Nectoux J, Degott C, et al. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003;124:651-659.
7. Paradis V, Benzekri A, Dargere D, Bieche I, Laurendeau I, Vilgrain V, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004;126:1323-1329.
8. Zeng W, Gouw AS, van den Heuvel MC, Zwiers P, Zondervan PE, Poppema S, et al. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietindriven sprouting neovascularization. HEPATOLOGY 2008;48:1517-1527.
9. Augustin HG, Koh GY, Thuston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-tie system. Nat Rev Mol Cell Biol 2009;10:165-177.
10. Makinde T, Agrawal DK. Intra and extravascular transmembrane signalling of angiopoietin-1-Tie2 receptor in health and disease. J Cell Mol Med 2008;12:810-828.
11. Taura K, De Minicis S, Seki E, Hatano E, Iwaisako K, Osterreicher CH, et al. Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis. Gastroenterology 2008;135:1729-1738.
12. Fabris L, Cadamuro M, Fiorotto R, Roskams T, Spirli C, Melero S, et al. Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polcystic liver diseases. HEPATOLOGY 2006;43:1001-1012.
13. Fabris L, Cadamuro M, Libbrecht L, Raynaud P, Spirli C, Fiorotto R, et al. Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development. HEPATOLOGY 2008;47:719-728.
14. Ward NL, Haninec AL, Van Slyke P, Sled JG, Sturk C, Henkelman RM, et al. Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice. Am J Pathol 2004;165:889-899.
15. Haninec AL, Voskas D, Needles A, Brown AS, Foster FS, Dumont DJ. Transgenic expression of angiopoietin 1 in the liver leads to changes in lymphatic and blood vessel architecture. Biochem Biophys Res Commun 2006;345:1299-1307.
16. Bioulac-Sage P, Laumonier H, Rullier A, Cubel G, Laurent C, Zucman- Rossi J, et al. Overexpression of glutamine synthetase in focal nodular hyperplasia: a novel easy diagnostic tool in surgical pathology. Liver Int 2009;29:459-465.
17. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, et al. Differential effects of NF-jB and p38 MAPK inhibitors and combinations thereof on TNF-a- and IL-1b-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol 2005;289:C1229-C1239.
18. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;47:242-248.
19. Bioulac-Sage P, Rebouissou S, Sa Cunha A, Jeannot E, Lepreux S, Blanc JF, et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology 2005;128:1211-1218.
20. Gouysse G, Frachon S, Hervieu V, Fiorentino M, d'Errico A, Dumortier J, et al. Endothelial cell differentiation in hepatocellular adenomas: implications for histopathological diagnosis. J Hepatol 2004;41:259-266.
21. Hirohashi K, Yamamotoa T, Tanaka S, Shuto T, Kubo S, Tanaka H, et al. Immunohistochemical demonstration of sinusoidal capillarization in human benign liver tumors: distinction from neoangiogenesis. Hepatol Res 2004;28:87-93.
22. Brindle NPJ, Saharinen P, Alitalo K. Signaling and functions of angiopoietin- 1 in vascular protection. Circ Res 2006;98:1014-1023.
23. Eklund L, Olsen BR. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 2006;312:630-641.
24. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, et al. Increased vascularization in mice overexpressing angiopoietin- 1. Science 1998;282:468-471.
25. Nykanen AI, Pajusola K, Krebs R, Keranen MAI, Raisky O, Koskinen PK, et al. Common protective and diverse smooth muscle cell effects of AAV-mediated angiopoietin-1 and -2 expression in rat cardiac allograft vasculopathy. Circ Res 2006;98:1373-1380.
26. Shim WSN, Ho IAW, Wong PEH. Angiopoietin: a TIE(d) balance in tumor angiogenesis. Mol Cancer Res 2007;5:655-665.